The prevailing paradigm in modern psychiatry has long focused on the question, "What is wrong with you?" This diagnostic lens seeks to categorize human suffering into discrete disorders, often attributed to biological malfunctions. However, a growing movement of survivors and clinicians, led by figures like Jacqui Dillon, argues for a fundamental shift toward a different inquiry: "What happened to you?"
This report examines the twenty-year journey of an individual—referred to here as the "subject"—who navigated the depths of what they term "mental hellness." It is a story that illustrates the trajectory of many patients: a path that begins with life’s stressors and physical symptoms, only to be consumed by a psychiatric system that prioritizes chemical intervention over contextual understanding.
Main Facts: The Inventory of a Two-Decade Intervention
The subject’s experience serves as a stark case study in psychiatric escalation. After twenty years within the system, a retrospective review of over 2,000 pages of medical records revealed the following scale of intervention:
- Diagnostic Labels: Five distinct psychiatric diagnoses were applied over two decades.
- Pharmacological Load: A total of 21 different psychiatric medications were prescribed.
- Biological Interventions: 39 rounds of Electroconvulsive Therapy (ECT), often referred to as electroshock.
- Iatrogenic Crises: Documentation of eight suicide attempts, many of which the subject now attributes to the profound neurological and emotional injury caused by heavy drugging and ECT.
- Recovery Outcome: Seven years after taking the final pill and ending a relationship with psychiatry—despite being told treatment would be lifelong—the subject reports a return of clarity, memory, and selfhood.
Chronology: The Descent into Medicalization
The Somatic Onset and Diagnostic Overshadowing
The subject’s journey did not begin in a psychiatric ward, but in the office of a cardiologist. Faced with the ordinary pressures of adulthood—work, parenting, and mounting responsibilities—the subject began experiencing physical symptoms, specifically heart palpitations.
A cardiologist diagnosed the condition as supraventricular tachycardia (SVT), a racing heart rhythm. The subject was prescribed a beta-blocker. However, the cardiologist also suggested that the symptoms might be psychological, recommending a return to a primary care physician to explore "depression."
This moment marked the beginning of "diagnostic overshadowing," a phenomenon where physical symptoms are attributed to psychiatric causes. Notably, beta-blockers are known to cause side effects such as fatigue, emotional flattening, and lethargy—symptoms that closely mimic clinical depression.
The "Chemical Imbalance" Narrative
Upon returning to a family doctor, the conversation shifted abruptly from cardiac health to mental health. The subject notes that there was little curiosity regarding their life context or stressors. Instead, the physician introduced the "chemical imbalance" theory.
"I was told that depression was caused by a ‘chemical imbalance’ in the brain," the subject recalls. "It was explained like insulin for diabetes—something measurable and manageable."
This framing served to de-contextualize the subject’s distress, moving it from a response to life events to a biological defect requiring lifelong medication. This narrative provided temporary comfort but effectively "narrowed the story," making further inquiry into the subject’s life unnecessary for the medical team.
Two Decades of Escalation
Once the initial diagnosis of depression was established, the system followed a pattern of escalation. When the first medication failed to "fix" the perceived imbalance, more were added. When medications led to side effects or worsening moods, new labels were applied.
This cycle led to 39 rounds of ECT and multiple hospitalizations. The subject describes this period as a "blur," with large segments of their life memory lost to the effects of the treatment. The "care" provided was a series of interventions that prioritized suppression of symptoms over the resolution of the underlying life stresses that had triggered the initial heart symptoms.
Tapering and The Return of Self
Nine years ago, the subject began the arduous process of tapering off psychiatric drugs. This was done with the support of a naturopath and a psychiatrist who was willing to oversee the withdrawal. Seven years ago, the subject took their last pill.
Contrary to the "deterioration" predicted by clinical staff, the subject experienced a slow but steady recovery. This recovery was not linear; the tapering process was physically and mentally demanding. However, as the drugs left the subject’s system, clarity and memory returned, leading to the eventual decision to investigate their own medical history.

Supporting Data: The Myths and Realities of the Biological Model
The subject’s story mirrors broader trends and data within the mental health field that challenge the traditional biological model.
The Serotonin Myth
The "chemical imbalance" theory mentioned by the subject’s doctor was a cornerstone of psychiatric marketing for decades. However, a landmark 2022 umbrella review published in Molecular Psychiatry by Joanna Moncrieff and colleagues found "no consistent evidence of there being an association between serotonin and depression, and no support for the hypothesis that depression is caused by lowered serotonin activity or concentrations."
The Rise of Polypharmacy
The subject’s use of 21 different drugs is an example of "psychiatric polypharmacy." According to research published in The Journal of Clinical Psychiatry, the percentage of office visits involving three or more psychiatric medications increased significantly over the last two decades. This practice often occurs without long-term safety data, leading to what clinicians call "prescribing cascades," where new drugs are prescribed to treat the side effects of previous ones.
The Impact of ECT
While the American Psychiatric Association (APA) maintains that ECT is a safe and effective treatment for "treatment-resistant" depression, critics point to the lack of long-term placebo-controlled trials. A 2020 review in Ethical Human Psychology and Psychiatry argued that there is no evidence that ECT is more effective than a sham (placebo) procedure beyond the treatment period, and it carries significant risks of permanent memory loss and cognitive impairment.
Official Responses and the Shifting Landscape
The psychiatric establishment and global health organizations have begun to clash over these issues.
The APA Position: The American Psychiatric Association continues to support the medical model, asserting that mental disorders are "real, treatable medical conditions" and that medications and ECT are vital tools in preventing suicide and managing severe symptoms. They argue that "biological, genetic, and environmental factors" all play a role.
The UN and WHO Shift: In a significant departure from the medical model, the United Nations and the World Health Organization (WHO) have recently called for a "revolution" in mental health care. Dr. Dainius Pūras, a former UN Special Rapporteur, has argued that the excessive use of psychotropic drugs and the focus on "chemical imbalances" has failed to improve global mental health. The WHO’s 2023 "Guidance on community mental health services" emphasizes human-rights-based approaches that move away from forced treatment and heavy medicalization.
Mad in America and Survivor Advocacy: Organizations like Mad in America provide a platform for "service users" and "survivors" to share stories that contradict the official medical narrative. Their stance is that much of what is called "mental illness" is a normal reaction to abnormal circumstances, such as trauma, poverty, and social isolation.
Implications: The High Cost of Mislabeling Humanity
The subject’s investigation into their 2,000 pages of records reveals a profound implication: the system can inadvertently create the very "illness" it seeks to treat.
The Iatrogenesis of Suicidality
The discovery of eight suicide attempts in the medical records—many of which were forgotten due to ECT-induced amnesia—highlights the risk of iatrogenic harm (harm caused by medical treatment). When a patient is told they have a "broken brain" and is subjected to treatments that flatten their emotions and erase their memories, the resulting despair can lead to suicidality, which is then often used by the system as justification for even more intensive "life-saving" intervention.
The Loss of Context
By framing the subject’s heart racing and life stress as a biological depression, the medical system effectively silenced the subject’s life story. The "what happened to you" (work stress, parenting, etc.) was replaced by "what is wrong with you" (chemical imbalance). This shift prevents patients from addressing the actual roots of their distress, potentially trapping them in a cycle of chronic "patienthood."
Conclusion: A Call for Intellectual Humility
The subject’s journey from "mental hellness" to recovery suggests that the certainty of psychiatric diagnosis often lacks a concrete foundation. As the subject noted, "There were no tests confirming what I had been diagnosed with. No scan, no marker. Nothing concrete behind the certainty."
The case highlights a critical need for "intellectual humility" in psychiatry. When the medical system turns normal human emotions—grief, stress, and trauma—into disorders of the brain, it risks convincing individuals that their very humanity is a malfunction. True care may require less focus on biological "fixing" and more focus on the complex, messy, and non-linear process of supporting individuals through the strains of being human.
